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Neuroregenerative therapies for central nervous system (CNS) injury, neurodegenerative
disease, or stroke require axons of damaged neurons to grow and re-innervate their
targets. However, mature mammalian CNS neurons do not regenerate their axons, limiting
recovery in these diseases. Although neurons’ intrinsic capacity for axon growth may
depend in part on the panoply of expressed transcription factors, epigenetic factors such
as the accessibility of DNA and organization of chromatin are required for downstream
genes to be transcribed. Thus, a potential approach to overcoming regenerative failure
focuses on the epigenetic mechanisms regulating regenerative gene expression in the
CNS. Here we review molecular mechanisms regulating the epigenetic state of DNA
through chromatin modifications, their implications for regulating axon and dendrite
growth, and important new directions for this field of study.
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INTRODUCTION
Epigenetics is the regulation of gene expression beyond the heri-
table DNA sequence (Bird, 2007), by enzymes and their substrate
modifications, which ultimately gate access to and transcription
from DNA (Reik, 2007), and thus may play role in expression of
regenerative genes in the nervous system. Central nervous system
(CNS) regenerative failure may be attributable to the devel-
opment of an inhibitory CNS environment by glial-associated
inhibitory molecules (Yiu and He, 2006), and by various cell-
autonomous factors (Sun and He, 2010). Intrinsic axon growth
ability also declines developmentally (Li et al., 1995; Goldberg
et al., 2002; Bouslama-Oueghlani et al., 2003; Blackmore and
Letourneau, 2006) and is dependent on transcription (Moore
et al., 2009). Several transcription factors have been identified
as regulators of axon growth and regeneration, for example,
Krüppel-like factors (KLFs), cAMP response element-binding
protein (CREB), c-Jun, Smad1, c-EBP, SOX11, STAT3, ATF3,
NFATs, and NFIL3 (Sun and He, 2010; Liu et al., 2011; Moore
and Goldberg, 2011). Because access to DNA through chromatin
remodeling is required for transcription factors to transcribe
their target genes, epigenetic mechanisms may also play a sig-
nificant role in regulating expression of pro-regenerative genes.
Remodeling chromatin through protein and DNA modifications
at specific loci not only passively gates accessibility of transcrip-
tion factors to gene promoters, but can also actively recruit
protein complexes which serve as scaffolds for specific transcrip-
tion factors to promote or repress transcription (Strahl and Allis,
2000). Specific epigenetic factors are now emerging as regulators
of chromatin remodeling that gate access to genes regulating axon
and dendrite growth and regeneration. This review will provide
critical analysis of the advances in the field of epigenetic regu-
lation of axon growth and regeneration, focusing on chromatin
remodeling enzymes which have been shown to play roles in neu-
rite growth, and emphasizing the experimental challenges that
need to be addressed.
ACETYLATION, HATs, AND HDACs
In eukaryotes, histone proteins H2A, H2B, H3, and H4 wrap
around DNA, and along with H1, form a nucleosome and gate
transcription factors’ access to DNA. Post-translational modifi-
cations of histone tails protruding from the nucleosome, and
of histones in the nucleosome core, regulate DNA accessibil-
ity through modifying nucleosome architecture and chromatin
structure (Figure 1) (Kouzarides, 2007). Combinations of vari-
ous post-translational histone modifications are associated with
differential regulation of chromatin and gene expression and
comprise the “histone code,” (Turner, 2007) which could in
principle encode axon regeneration programs regulating multi-
ple pro-regenerative genes. The most prominent type of post-
translational histone modification is the acetylation of lysine
residues in histone tails. Thus, one of the key mechanisms reg-
ulating transcription factors access to target gene promoters is
regulation of post-translational acetylation and deacetylation of
histone tails by histone acetylases (HATs) and histone deacetylases
(HDACs), respectively (Kouzarides, 2007). Epigenetic regulation
of survival in neurodegenerative conditions by HATs and HDACs
has been well described (Glozak et al., 2005; Saha and Pahan,
2006; Gaub et al., 2010), and their role in regulation of axon and
dendrite growth is becoming more apparent (Gaub et al., 2010,
2011).
Does epigenetic regulation of transcriptional activity in mam-
malian CNS neurons, which lose their intrinsic neurite growth
capacity during maturation (Goldberg et al., 2002; Moore et al.,
2009), change developmentally? This question could be addressed
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FIGURE 1 | HATs and HDACs can regulate neurite growth through
chromatin remodeling or post-translational modifications of
transcription factors and cytoplasmic proteins. HAT, histone acetylase;
HDAC, histone deacetylase; A, acetylation; TF, transcription factor
(Figures 1–3 adapted in part from Levenson and Sweatt (2005)).
in part by assessing whether histone acetylation levels, which
signify transcriptional activity, change developmentally in the
mammalian CNS neurons. Immunoblotting showed that in at
least two types of CNS neurons, cortical neurons, and cerebel-
lar granule neurons, histone 3 (H3) K9/14 acetylation decreases
developmentally (Gaub et al., 2010). Because postnatal and adult
cortical and cerebellar homogenates may include glial cells that
are almost absent from the embryonic homogenates, it is possi-
ble that the decrease in the H3K9/14 immunoblotting band was
a result of glial protein fraction increase in the input material; it
is not known whether there is developmental regulation of his-
tone acetylation in glial cells. Comparing histone acetylation in
acutely purified homogeneous cultures—devoid of glial cells—of
embryonic versus mature neurons using immunoblotting and in
brain sections using immunohistochemistry would corroborate
this finding. The developmental regulation of epigenetic regu-
lators and whether they regulate intrinsic axon growth capacity
remains to be further explored.
Are these epigenetic enzymes regulated after injury? The
expression profile of epigenetic regulators points to attenuation
of transcription following stroke in neurons exhibiting axonal
sprouting (Li et al., 2010). Cortical neurons that grow short neu-
rites after stroke and adjacent neurons that did not grow neurites
were laser-dissected, and a comparison of their gene expression
profiles revealed that HDAC4 expression was upregulated whereas
p300, a HAT, was downregulated in the axon sprouting neu-
rons (Li et al., 2010). It remains to be investigated whether this
trend in expression change of epigenetic regulators functionally
affects transcriptional activity and neurite growth, and whether
this leads to differential epigenetic regulation of axon growth pro-
grams or affects axon growth through non-chromatin remodeling
factors. Although an HDAC inhibitor trichostatin A (TSA) was
neuroprotective after stroke (Endres et al., 2000b), this may have
been mediated by HDAC inhibition in neurons, glia, or immune
cells to promote neurite growth or survival. Future investigations
will shed light on this question.
Can neurite growth be controlled epigenetically? In support
of epigenetic regulation of neurite growth, the HDAC class
I and II inhibitor TSA increased neurite growth in postnatal
day 7 cerebellar granule neurons on permissive and inhibitory
substrates—similar to a known enhancer of axon growth cAMP
analog (dbcAMP) (Neumann et al., 2002)—and enhanced
expression of axonal outgrowth marker GAP43 (Tedeschi et al.,
2009; Gaub et al., 2010). Furthermore, immunoblotting and
immunofluorescence revealed that TSA induced H3K9/14 hyper-
acetylation (Gaub et al., 2010). Measuring H3 total levels would
help resolve whether TSA increased H3 acetylation, expression, or
both. Did TSA-inducedHDAC inhibition increase neurite growth
through facilitating increased transcription at one or more target
genes? TSA failed to rescue neurite growth suppressed by tran-
scriptional inhibitor actinomycin D, suggesting that transcription
is required for TSA-induced neurite growth (Gaub et al., 2010).
This question was explored further by investigating whether HATs
known to acetylate H3 at K9/14 modulate normal and TSA-
induced neurite outgrowth, and if so, whether this effect is associ-
ated with regulation of transcription. RT-PCR showed that cere-
bellar granule neurons cultured for 24 h on an inhibitory myelin
substrate decreased expression of HATs CBP/p300 and P/CAF,
whereas TSA increased their expression on both permissive and
inhibitory substrates. Furthermore, chromatin immunoprecipi-
tation (ChIP) revealed that TSA increased H3K9/14 acetylation
on CBP/p300 and P/CAF promoters, but not on a promoter of
a control RPL13a gene (Gaub et al., 2010). These findings sug-
gest that TSA induces promoter-specific H3 hyperacetylation,
and that CBP/p300 and P/CAF are potential mediators of the
TSA-induced increase and myelin-induced decrease in neurite
growth, highlighting the importance of transcriptional regulation
in neurite growth. It remains to be clarified whether TSA’s inhibit-
ing HDACs affects neurite growth by epigenetically augmenting
transcription, or by directly acetylating and regulating specific
transcription factors, α-tubulin (Hubbert et al., 2002; Rivieccio
et al., 2009; Kim et al., 2010; Tapia et al., 2010), or other proteins
that also depend on some basal transcriptional activity suppressed
by actinomycin D.
To address direct role of HATs in epigenetic transcriptional
regulation of neurite growth, it is important investigate whether
HAT activity is required for normal neurite growth and whether
it is sufficient to increase neurite growth. Knocking-down expres-
sion of CBP/p300 or P/CAF in postnatal day 7 cerebellar gran-
ule neurons cultured for 24 h decreased neurite growth on an
inhibitory substrate, and blocked TSA-induced increase in neu-
rite growth on both permissive and inhibitory substrates (Gaub
et al., 2010). Although immunofluorescence showed decreased
H3K9/14 acetylation also on a permissive substrate without TSA,
neurite growth did not decrease significantly after 24 h in cul-
ture. In contrast, p300 overexpression increased neurite growth
in postnatal day 7 cerebellar granule neurons cultured for 24 h
on both permissive and inhibitory substrates, similar to TSA, and
in a follow-up experiment p300 overexpression in postnatal day
7 retinal ganglion cells (RGCs), a type of CNS neuron, increased
neurite growth at three days in culture after transduction (Gaub
et al., 2010, 2011). Other data suggests that p300 knockdown
decreases axon but not dendrite growth, and p300 overexpres-
sion had no effect on neurite growth of postnatal day 6 cerebellar
granule neurons cultured four days on a permissive substrate
(Ikeuchi et al., 2009). It is possible that time in culture or technical
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differences accounted for the opposite results in cerebellar granule
neurons; however, further investigation is warranted.
These experiments suggest that HATs CBP/p300 and P/CAF
are required for the hyperacetylation-induced increase in neu-
rite growth. It remains to be clarified whether HAT activity is
required for normal neurite growth on a permissive substrate over
24 h in culture, and if so, whether it is axon-, dendrite, or neu-
ronal cell type-specific, and whether the p300 overexpression or
TSA-induced hyperacetylation effect on neurite growth is only
transient, at least on a permissive substrate. Furthermore, because
actinomycin D suppressed normal neurite growth even within
24 h, it is possible that other HATs are also involved in normal
neurite growth; it is also possible that the low-level of transcrip-
tional activity remaining after RNAi-mediated HATs knockdown
may suffice for maintenance of normal neurite growth in the
short-term. Identifying other HDACs and HATs that play a role in
neurite growth and whether they could compensate for each other
is another question which needs to be addressed. Furthermore,
these findings need to be tested in other types of neurons, at
different time-points, and importantly, in vivo.
Is there evidence for such epigenetic regulation in vivo?
Looking at expression and acetylation levels by immunofluores-
cence in retinal sections, recent experiments revealed that p300
expression and H3K18 acetylation in RGCs increases during mat-
uration after P0 and then decreases in adulthood, although CBP
expression appeared to remain elevated at all time points (Gaub
et al., 2011). Again measuring H3 total levels would address
whether this change occurs in H3 acetylation, expression, or
both, and staining for H3K9/14 would provide additional sup-
port consistent with the in vitro data from cortical and cerebellar
granule neurons referenced above. Immunofluorescence analysis
also showed that although H3K18 acetylation did not change 72 h
after optic nerve crush, p300, and CBP levels decreased (Gaub
et al., 2011); perhaps other HATs could compensate for H3K18
acetylation.
Could TSA-induced HDAC inhibition increase axon regenera-
tion in vivo? Although TSA increased RGC survival 14 days after
optic nerve crush, it had no significant effect on axon regener-
ation. Immunofluorescence analysis, however, revealed that TSA
does not affect p300 expression but increases H3K18 acetylation
and CBP expression (Gaub et al., 2011). Testing TSA effects on
RGC axon growth in vitro could resolve whether its failure to
enhance axon regeneration in vivo was due to an inhibitory in
vivo environment, or due to cell-type differences.
Could upregulating p300 increase RGCs axon regeneration
in vivo? Indeed, p300 overexpression increased the number of
regenerating axons after optic nerve crush, along with H3K18
acetylation, although survival was not affected (Gaub et al., 2011).
Furthermore, this effect was additive to a lens injury-induced
regeneration, suggesting that either p300 affects neurite growth
through a different mechanism, or augments lens injury-induced
pathways, or both (Gaub et al., 2011). That HDAC inhibition
affected only survival and p300 overexpression affected only axon
regeneration raises the interesting and important premise that
these enzymatic regulations activate specific cellular phenotypes.
Importantly, ChIP analysis of retinas with p300 overexpression
after optic nerve crush revealed increased H3K18 acetylation and
p300 occupancy on the promoters of pro-growth genes GAP43,
Coronin1b, and Sprr1a, and RT-PCR confirmed their upreg-
ulation, supporting the biological plausibility of acetylation-
dependent epigenetic regulation of neurite growth (Gaub et al.,
2011). However, immunofluorescence analysis of retinal section
showed that p300 overexpression after optic nerve crush also led
to hyperacetylation-dependent activation of axon-growth pro-
moting transcription factors p53 and C/EBP (although C/EBP
basal level was not controlled for) (Gaub et al., 2011), leaving
unresolved, in this case, the contribution of epigenetic regulation
vs. other acetylation-dependent effects to promoting axon growth
and regeneration (see below).
SnoN CHROMATIN REMODELING FACTOR
Differential histone acetylation regulating axon growth may also
be modulated by SnoN, which directly interacts with p300 and
can act as a transcriptional repressor (Figure 2) (Ikeuchi et al.,
2009). The ability of SnoN to increase axon growth is depen-
dent on p300, as overexpression of the active form of SnoN
in cerebellar granule neurons failed to promote axon growth if
p300 expression was knocked-down, raising a possibility that
SnoN may play a role in chromatin remodeling in coopera-
tion with p300 to differentially activate axon growth-promoting
gene programs (Ikeuchi et al., 2009). It is possible that although
p300 is necessary for SnoN to promote axon growth, the actual
effector of SnoN that promotes axon growth may be transcrip-
tion factors, for example Smads (Wu et al., 2002), or another
non-chromatin remodeling factor. Thus, it remains to be inves-
tigated whether SnoN affects neurite growth through epige-
netic mechanisms, traditional gene regulation, other ways, or a
combination.
SET-β PROTEIN
The “patient SE translocation β” (SET-β) oncogene (von Lindern
et al., 1992) is another chromatin remodeling factor that may reg-
ulate axon growth (Trakhtenberg et al., 2011). Set-β could modify
chromatin in multiple ways, by chaperoning histones, by govern-
ing access to chromatin (Gamble and Fisher, 2007) by preventing
FIGURE 2 | Chromatin remodeling factors SnoN, Set-β, and nBAF could
affect neurite growth through regulating histone or transcription
factor acetylation, histone chaperoning, or nucleosome structure.
HAT, histone acetylase; A, acetylation; TF, transcription factor; nBAF,
neuron-specific Brg/Brm-associated factor.
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histone acetylation as part of the INHAT (inhibitor of acetyl-
transferases) complex (Seo et al., 2001; Loven et al., 2003), by
recruiting HDACs directly (Li et al., 2005; Wagner et al., 2006) or
by otherwise regulating transcription (Figure 2) (Okuwaki and
Nagata, 1998). For example, glucocorticoid receptor transcrip-
tion factor can displace Set-β from a histone, permitting histone
acetylation and promoting transcription (Ichijo et al., 2008),
whereas estrogen receptor (ER) transcription factor recruits Set-β
to mask histone acetylation sites, thereby inhibiting transcription.
Yet silencing Set-β also prevents ER from activating transcription
because of consequent histone hypermethylation, suggesting that
basal level of Set-β along with hypomethylation at the promoter
are necessary for initiation of the ER-mediated transcription
(Wagner et al., 2006).
Set-β can also regulate transcription factors directly, for exam-
ple, Set-β interacts (Miyamoto et al., 2003) with the KLF fam-
ily of transcription factors which regulate axon growth (Moore
et al., 2009), and can modulate nuclear PP2A (Li et al., 1996;
McCright et al., 1996) implicated in neuronal differentiation
(Van Kanegan and Strack, 2009) and axon growth (Zhu et al.).
Thus, it remains to be investigated whether Set-β regulates axon
growth epigenetically—and if so through which mechanism of
chromatin remodeling—or thorough regulating other nuclear
factors. Interestingly, Set-β is developmentally upregulated in rat
RGCs’ nuclei, and overexpression of Set-β suppresses axon growth
whereas its knockdown promotes axon growth (Trakhtenberg
et al., 2011), supporting a hypothesis that Set-β is a physiologic
regulator of axon growth during development. The molecular
mechanisms for these effects are not yet known.
nBAF COMPLEX
SWI/SNF complex is a well-studied chromatin-remodeler (Wang
et al., 1996). These enzymes all contain an ATPase catalytic
center, and through altering nucleosome structure either move
the nucleosome relative to DNA or even eject histones, thereby
gating access to DNA (Varga-Weisz, 2001). One such SWI/SNF-
like chromatin-remodeling enzymatic complex, neuron-specific
Brg/Brm-associated factor (nBAF), regulates dendrite growth and
axonmyelination (Figure 2) (Wu et al., 2007). Knocking out neu-
ronal subunit BAF53b of the nBAF complex in mice reduced
dendrite growth and arborization in cortical neurons, cerebellar
granule neurons, and hippocampal neurons in vivo (Wu et al.,
2007). The effect was similar in hippocampal neurons in vitro.
The knockout also reduced axonal myelination, with an observed
reduction in the size of the myelinated axon bundles in the hip-
pocampus. Electron microscopy revealed that substantially fewer
axons were myelinated within these axon bundles (Wu et al.,
2007). It is also possible that fewer axons grew in the knockout
animals, requiring further examination of possible defects in axon
morphogenesis and function. Because BAF53b is not expressed
in the oligodendrocytes which make myelin (Olave et al., 2002;
Wu et al., 2007), it is likely that the knockout in neurons caused
axons to be undermyelinated, rather than a defect in oligodendro-
cytes. This could be due to a failure of neurons to secrete factors
or maintain levels of electrical activity that support growth or dif-
ferentiation of oligodendrocytes (Barres and Raff, 1993; Wu et al.,
2007). It is also possible that BAF53b is necessary for axons to
be receptive to myelination, or its absence in progenitors could
result in differentiation of defective oligodendrocytes. Possible
roles of nBAF in axon formation and oligodendrocyte differen-
tiation require further examination and as above, it remains to
be investigated whether discrete pro-regenerative programs are
differentially affected by the nBAF complex or its subunits.
DNA AND HISTONE METHYLATION
Along with histone and other protein acetylation, direct DNA
methylation is a key mode of epigenetic regulation (Figure 3)
(Kumar et al., 1994). Mammalian (cytosine-5) DNA methyl-
transferases 3a and 3b (Dnmt3a and -3b) catalyze de novo DNA
methylation, whereas Dnmt1 is responsible for maintenance of
DNA methylation (Kumar et al., 1994). Dnmt activity is high
in normal adult brain neurons (Brooks et al., 1996) and DNA
methylation levels are increased in the brain after ischemic insults,
whereas reducing DNA methylation—particularly by decreasing
expression of Dnmt1 (Endres et al., 2001)—is neuroprotective
after stroke (Endres et al., 2000a; Qureshi andMehler, 2010). The
role of DNA methylation in axon and dendrite growth has been
studied only scarcely. Dnmt3b positively regulates neurite growth
in PC12 cells, induced by NGF to differentiate into a neuron-
like phenotype, by recruiting HDAC—rather than by direct DNA
methylation—to the promoter of the axon growth-suppressing
gene T-cadherin (Fredette et al., 1996), thereby negatively regu-
lating its expression, releasing the cells from T-cadherin-mediated
inhibition, and thereby promoting neurite growth (Bai et al.,
2006). Thus, a possibility of Dnmts affecting histones’ post-
translational modification needs to be addressed in investigation
of their roles in axon growth. Double conditional knockout of
Dnmt3a and Dnmt1 in postmitotic postnatal forebrainmice neu-
rons, on the other hand, did not impair axonal development,
although synaptic plasticity was defective (Feng et al., 2010).
Even if it is not critical for axon growth during development,
it is still possible that diminished Dnmt3a expression or activity
might augment CNS damage after injury and hinder regenera-
tive therapies. For example, folic acid (FA) promotes CNS axon
FIGURE 3 | Regulation of cellular methylation could affect neurite
growth though modifying DNA or histones, as well as by recruiting
HDACs to promoters. HDAC, histone deacetylase; M, methylation; A,
acetylation; TF, transcription factor; HMT, histone methyltransferase; HDM,
histone demethylase; DNMT, DNA methyltransferase; DNDM, DNA
demethylase.
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regeneration and a folate receptor isoform α (Folr1)—which can
transport FA into neurons—is upregulated in dorsal root gan-
glia (DRG) neurons after spinal cord injury (Iskandar et al.,
2010). Reduced Folr1 expression in Folr1+/− mice or inhibition
of Dhfr—an enzyme catalyzing conversion of FA into tetrahy-
drofolate, which plays role in cellular metabolism—blocked FA-
induced axon regeneration (Iskandar et al., 2010). Dnmt3a and
Dnmt3b levels and global DNA methylation in the spinal cord
decreased after spinal cord injury, but were restored by FA—a
primary source for methyl donors utilized by Dnmts (Iskandar
et al., 2010)—suggesting that a possible mechanism of action for
FA-promoted regeneration is through DNAmethylation. How FA
increases Dnmt levels, and whether this depends on a pathway
through which FA increased methyl donor substrate availability,
remains to be investigated. Similarly, promoter methylation of the
Gadd45a gene—which promoted neurite outgrowth in N1E-115
neuroblastoma cells (Yamauchi et al., 2007)—was increased after
spinal cord injury and further hypermethylated by FA, suggesting
specific epigenetic regulation of pro-regenerative gene expres-
sion by methylation (Figure 3). Because DNA hypermethylation
is typically associated with silencing gene expression, it is impor-
tant to examine how the expression of the Gadd45a gene product
was affected. An inclusion of methylation assays for a non-
axon growth-related gene promoters and several prominent axon
regeneration promoting genes, as well as RT-PCR to measure
effect on expression, could further support the implication that
promoter methylation can differentially regulate pro-regenerative
gene expression.
It is possible that in both cases, stroke and spinal cord injury,
changes in DNA methylation were primarily due to changes in
glial and immune cells’ methylation, as the DNA from whole tis-
sue was used in both cases. It is also possible that differences
between effects of methylation on non-neuronal cells accounted
for the opposite effects of methylation on neuroprotection and
regeneration in these tissues. Because glia and immune cells play
critical roles in the injured CNS (Trakhtenberg and Goldberg,
2011), it is possible that, for example, regulating DNA methyla-
tion in these cells modulated immunosuppression and ensuing
inflammatory damage, which also inhibits axon regeneration. It
is also possible that in both cases DNA methylation reflected
primarily trends in neuronal DNA methylation, which could
differ between brain stroke and spinal cord injury models or
between the tissues. An interaction between the effects of neu-
ronal and glial/immune cell DNA methylation patterns may also
affect CNS differently after brain stroke and spinal cord injury.
Thus, it is important to re-examine these questions with atten-
tion to changes in DNA methylation in specific cell types and
include overexpression or knockdown of Dnmts, individually or
in combinations.
Interestingly, histone methylation also modifies chromatin
structure and gene regulation (Kouzarides, 2007; Verrier et al.,
2011), and a methyltransferase which can methylate histones—
protein arginine N-methyltransferase 1 (PRMT1)—was shown
to be necessary for neurite outgrowth in the Neuro-2a cell line
(Figure 3) (Miyata et al., 2008). Neural-specific histone lysine-
specific demethylase 1 (nLSD1/KDM1) was also shown to reg-
ulate neurite growth of cortical neurons (Zibetti et al., 2010).
nLSD1 was either knocked-down or overexpressed in cultured
embryonic rat cortical neurons and neurite growth decreased or
increased, respectively (Zibetti et al., 2010). It will be important
to test nLSD1’s axon regenerative potential in a CNS injury model
in vivo. In Drosophila, deletion of another histone demethylase,
DMEL/KDM4a, did not cause apparent abnormalities in axon
or dendrite morphogenesis and growth during development. It
remains to be investigated whether its mammalian homolog reg-
ulates neurite growth in the mammalian CNS (Lorbeck et al.,
2010). In contrast to histone demethylases, DNA demethylases
have not yet been studied extensively and investigation of their
role in axon growth is clearly warranted. However, differentially
regulating levels of histone methyltransferases vs. Dnmts could
affect availability of methyl donors and, in turn, modulate methy-
lation of targets which regulate axon growth (Mato and Lu,
2007).
CHROMATIN-DEPENDENT AND -INDEPENDENT
REGULATION OF NEURITE GROWTH
Most of the chromatin remodeling studies discussed in this review
have converged on the importance of histone-associated chro-
matin modifications. Histone acetylation and methylation reg-
ulates chromatin remodeling, but acetylation is also a common
mode of post-translational regulation of transcription factors and
cytoplasmic proteins (Sadoul et al., 2011); regulation of transcrip-
tion factors (e.g., STAT1) (Mowen et al., 2001) and other proteins
by methylation is now also well-established (Paik et al., 2007).
Manipulating cellular acetylation or methylation could thus work
through chromatin remodeling as well as through regulation of
various other proteins which could regulate neurite growth. For
example, HDAC class I and HDAC6 also could directly regu-
late neurite growth independently of epigenetic effects on tran-
scription through deacetylation of α-tubulin and other proteins
(Hubbert et al., 2002; Rivieccio et al., 2009; Kim et al., 2010; Tapia
et al., 2010). Furthermore, p300 acetylates transcription factor
KLF4 (Evans et al., 2007) and might also promote neurite growth
by increasing α-tubulin acetylation (Ferreira and Caceres, 1989;
Veldman et al., 2010) through inhibiting cytoplasmic HDAC6,
which normally deacetylates α-tubulin (Han et al., 2009). Set-β
can also mask an acetylation site on KLF transcription factors
and potentially regulate their effects on neurite growth-related
transcription (Miyamoto et al., 2003). In yet another example,
axon growth-promoting transcription factor p53 can be acti-
vated through accumulated acetylation after TSA inhibition of
HDACs (Gaub et al., 2010), which may be in parallel to, or down-
stream of, observed concurrent histone-H3 acetylation (Gaub
et al., 2010), again suggesting that acetylation of axon-growth
promoting transcription factors may be an important component
of the hyperacetylation effect on neurite growth. Such multiple
roles of acetylation and methylation in other, non-chromatin-
relevant cellular processes pose a challenge to experimental dis-
cernment of epigenetic and non-epigenetic regulation of neurite
growth.
DISCUSSION
Taken together, these findings raise the hypothesis that chromatin
gatekeepers are as relevant for activation of pro-regenerative gene
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expression as the levels of pro-regenerative transcription fac-
tors themselves. It is interesting to hypothesize that epige-
netic pathways may play wider range of roles in neurons than
in other cell types, as mammalian neurons are not generally
replaced through life and thus may be more reliant on such
cellular regulatory mechanisms. This notion is supported by
presence of neuron-specific epigenetic factors like nBAF and
nLSD1 discussed above, which may contribute to unique neu-
ronal adaptations such as transcription-dependent neuroplas-
ticity and learning (Kandel, 2001; Wu et al., 2007) or axon
and dendrite regeneration. Such a prospect is intriguing as
current techniques for experimental manipulation of transcrip-
tion factor expression in neurons allows the study of only
one or a few transcription factors at a time. Unlocking the
activity of multiple pro-regenerative transcription factors and
allowing greater access—and maybe even active recruitment
(Strahl and Allis, 2000)—to promoters of pro-regenerative genes,
may prove a powerful approach to promoting regeneration;
the same would be true of manipulating chromatin to block
access to gene loci that inhibit regeneration. Exploring how
manipulation of the upstream regulators of HATs/HDAC and
Dnmts (Saha and Pahan, 2006), or other chromatin modify-
ing factors, such as histone chaperones, ATP-dependent chro-
matin remodeling complexes, non-coding RNAs (Goldberg et al.,
2007; Gupta et al., 2010), and regulators of histone methyla-
tion, phosphorylation, and ubiquitination (Kouzarides, 2007),
should hold considerable promise for progress in the field of
neuroregeneration.
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